Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

Last Close
Dec 06 04:00PM ET
2.51
Dollar change
+0.06
Percentage change
2.45
%
Index- P/E- EPS (ttm)-3.99 Insider Own40.31% Shs Outstand9.66M Perf Week-0.40%
Market Cap25.45M Forward P/E- EPS next Y-3.92 Insider Trans0.00% Shs Float7.19M Perf Month-34.64%
Income-43.37M PEG- EPS next Q-0.93 Inst Own25.09% Short Float0.55% Perf Quarter-48.14%
Sales50.00M P/S0.51 EPS this Y71.63% Inst Trans2.24% Short Ratio0.86 Perf Half Y-69.35%
Book/sh5.96 P/B0.42 EPS next Y-60.66% ROA-31.69% Short Interest0.04M Perf Year-56.80%
Cash/sh5.89 P/C0.43 EPS next 5Y14.50% ROE-51.99% 52W Range2.08 - 11.30 Perf YTD-69.01%
Dividend Est.- P/FCF- EPS past 5Y- ROI-59.07% 52W High-77.79% Beta0.68
Dividend TTM- Quick Ratio3.26 Sales past 5Y26.65% Gross Margin93.34% 52W Low20.67% ATR (14)0.23
Dividend Ex-Date- Current Ratio3.26 EPS Y/Y TTM55.10% Oper. Margin-91.51% RSI (14)33.40 Volatility6.17% 9.35%
Employees151 Debt/Eq0.04 Sales Y/Y TTM143.30% Profit Margin-86.74% Recom1.00 Target Price36.25
Option/ShortYes / Yes LT Debt/Eq0.02 EPS Q/Q36.09% Payout- Rel Volume1.09 Prev Close2.45
Sales Surprise-24.75% EPS Surprise14.06% Sales Q/Q-31.51% EarningsNov 14 AMC Avg Volume46.20K Price2.51
SMA20-9.62% SMA50-27.42% SMA200-57.66% Trades Volume50,173 Change2.45%
Date Action Analyst Rating Change Price Target Change
Nov-15-24Reiterated RBC Capital Mkts Outperform $50 → $48
Dec-02-22Downgrade BofA Securities Buy → Underperform $0.50
Dec-02-22Downgrade BofA Securities Buy → Underperform
Nov-12-21Downgrade Morgan Stanley Overweight → Equal-Weight $6
Apr-08-21Initiated Morgan Stanley Overweight $19
Nov-03-20Initiated Truist Buy $21
Oct-26-20Initiated JMP Securities Mkt Outperform $19
Oct-19-20Resumed H.C. Wainwright Buy $16
Sep-27-19Initiated H.C. Wainwright Buy $15
May-13-19Initiated RBC Capital Mkts Outperform $23
Nov-22-24 06:51AM
06:35AM
Nov-14-24 04:05PM
Nov-11-24 04:05PM
Oct-31-24 09:17AM
07:30AM Loading…
Oct-30-24 07:30AM
Sep-24-24 07:30AM
Sep-02-24 09:55AM
Aug-30-24 08:00AM
Aug-28-24 08:57AM
Aug-08-24 04:30PM
Aug-07-24 09:55AM
Aug-01-24 10:01AM
Jul-22-24 08:30AM
Jul-08-24 07:01AM
06:32AM Loading…
Jul-02-24 06:32AM
Jul-01-24 04:31PM
Jun-04-24 01:00PM
May-30-24 04:30PM
May-23-24 05:01PM
May-16-24 02:27PM
May-09-24 11:55AM
07:01AM
Apr-25-24 07:01AM
Apr-24-24 12:31PM
07:01AM
Apr-16-24 04:30PM
Apr-10-24 07:01AM
Mar-22-24 01:52PM
08:15AM
07:01AM Loading…
07:01AM
Mar-06-24 07:01AM
Feb-02-24 12:00PM
Jan-29-24 08:01AM
Jan-16-24 07:01AM
Dec-21-23 09:15AM
07:01AM
Nov-20-23 07:01AM
Nov-09-23 08:39AM
07:01AM
Nov-03-23 12:01PM
Nov-02-23 04:01PM
Oct-22-23 06:01AM
Oct-18-23 07:01AM
Sep-13-23 08:45AM
Sep-12-23 07:01AM
Sep-06-23 08:17PM
07:01AM
Aug-15-23 10:20AM
Aug-10-23 08:40AM
07:01AM
Aug-03-23 07:01AM
Jul-12-23 07:22AM
Jun-10-23 05:00AM
May-31-23 09:30PM
04:45PM
May-16-23 06:08AM
May-11-23 08:25AM
07:01AM
May-09-23 05:35PM
07:01AM
May-04-23 07:02AM
07:01AM
Apr-26-23 11:30AM
Apr-19-23 07:00AM
Apr-14-23 04:01PM
Mar-18-23 03:12AM
Mar-17-23 06:35AM
Mar-16-23 04:18AM
Mar-15-23 08:15AM
07:00AM
Mar-13-23 07:00AM
Mar-08-23 07:00AM
Feb-13-23 07:00AM
Feb-07-23 07:00AM
Jan-04-23 07:00AM
Dec-20-22 09:11AM
Dec-15-22 07:00AM
Nov-30-22 07:00AM
Nov-16-22 05:39AM
Nov-14-22 08:15AM
07:00AM
Nov-08-22 03:40PM
Nov-07-22 10:00AM
07:00AM
Nov-02-22 10:01AM
07:00AM
Oct-20-22 07:00AM
Sep-29-22 12:00PM
Sep-27-22 08:07AM
Sep-07-22 07:00AM
Aug-11-22 08:15AM
07:00AM
Aug-04-22 07:00AM
Jul-25-22 08:00AM
Jul-08-22 07:27AM
Jun-21-22 09:00AM
Jun-09-22 07:00AM
Jun-05-22 09:00AM
Jun-03-22 07:00AM
HOOKIPA Pharma, Inc. is a clinical stage biopharmaceutical company, which engages in developing pharmaceutical products to prevent and cure infectious diseases and cancer. The firm also focuses on immunotherapeutics based on its proprietary arenavirus platform that is designed to reprogram the body's immune system. The company was founded by Rolf M. Zinkernagel, Andreas Bergthaler, Lukas Flatz, and Daniel D. Pinschewer in 2011 and is headquartered in New York, NY.